4 November 2025

A design for life: Unlocking the potential of life sciences developments

The UK’s diverse life sciences sector represents some of the most pioneering medical and scientific research anywhere in the world.

To spur growth in the sector, the UK government has launched a range of dedicated funds and strategies, including the £520m Life Sciences Innovative Manufacturing Fund. This offers capital grants to support manufacturing of medicines, diagnostics, and MedTech, and is intended to help boost economic growth, bolster the manufacturing sector, and drive innovation in health technologies.

Huseyin Hussein

But what exactly does the life sciences sector encompass? And what about the buildings which are home to this leading-edge work? Waterman’s Director, Huseyin Hussein, told us more:

“The life sciences sector is truly vast, including everything from Biopharmaceutical Tech, and Medical Tech, to Genomics and beyond, and with each of these sub-sectors comes unique requirements for the facilities they call home. However, with the pace of growth seen across the sector, demand for high quality life sciences space continues to outstrip supply, particularly in the ‘Golden Triangle’ of London, Oxford, and Cambridge.”

Demand vs Supply: A focus on functionality

Keeping up with this demand has led to facilities being designed more for flexibility than for a specific function, Huseyin says: “Historically, we’ve been focused on meeting the demand for lab space as quickly as possible, catering to a wide spectrum of prospective life sciences tenants. This approach has left little opportunity to develop design-optimised and efficient spaces, particularly with the rise of AI-enabled research driving innovation at an exponential rate. To fully unleash the potential of life sciences operations and support this innovation, designs have to be carefully aligned to the intended functionality. It’s crucial to consider the spatial requirements, equipment loadings, desired operational conditions, core services supplies, handling of laboratory waste and much more besides, all whilst designing-in a degree of flexibility to suit future needs.”

Looking to the immediate future, a major development surge in this sector is on the horizon, Huseyin says: “With approximately four million sq ft of life sciences space expected to be delivered over the next two years, half of which will be within the Golden Triangle, we now have an opportunity to align designs more closely with emerging industry trends and demands, as we recognise these are increasingly shaped by infrastructure limitations, planning complexities, and funding challenges. Whilst questions around talent retention and infrastructure remain, it looks likely that the UK’s world-class universities, NHS integration, and clusters such as Cambridge and King’s Cross provide a foundation that, if supported by targeted policy and investment, can deliver global impact.”

Prioritising site selection

It’s clear, then, that the British life sciences industry is making a name for itself at a global scale, driven by the London and Oxbridge education power houses. And with significant growth potential evident, it’s likely to prove a boon for the British economy for years to come. But how do we go about finding the right locations for the developments required to support this growth, and how do we address the issues around infrastructure and planning constraints? That’s where targeted site selection comes in.

With brownfield sites often prioritised under local development plans, early site appraisal is vital to ensuring successful planning outcomes. Waterman’s Environmental Regional Director, Polly Clifton, explains why this is so important:

“Brownfield regeneration sites are attractive to life sciences developers since they are often situated in key locations close to talent pools, existing infrastructure, and established transport links. However, they can also have complex environmental issues, or pasts which involve industrial processes and historic contamination, so early engagement with environmental specialists is extremely important to ensure these risks are identified and mitigated, and that the planning process is then navigated as smoothly as possible.”

Looking to the positives, Polly continues: “Despite the challenges, these sites often represent an opportunity to boost occupier wellbeing with the provision of on-site green space, amenities, and the prioritisation of active travel, whilst also benefiting nature by targeting biodiversity net gain. That’s why placemaking has become increasingly important for life sciences schemes, and businesses recognise that they have to offer lifestyle-boosting features if they are to attract the best talent. Ultimately, this can be good news for all, since these schemes actively seek to deliver developments which are beneficial to employees, nature, and the wider community.”

Cambridge Science Park scheme, spanning 23-acres in central Cambridge’s Cherry Hinton area, this major project will deliver one million sq ft of space across seven buildings. As the former home of a cement works, the site will undergo extensive remediation, and significant ecological improvements will be made which will see the lakes at Burnside re-opened to the public.

Precision in placemaking

Delivering optimum facilities within a development which champions wellness and community engagement is precisely the aim of Mission Street’s and BGO’s Cambridge Science Park scheme. Spanning 23-acres in central Cambridge’s Cherry Hinton area, this major project will deliver one million sq ft of space across seven buildings. As the former home of a cement works, the site will undergo extensive remediation, and significant ecological improvements will be made which will see the lakes at Burnside re-opened to the public. With accessibility and sustainable travel a core consideration, new pedestrian and cycle paths will be included, linking the park to the central railway station in just ten-minutes’ cycle.

Embracing circularity through asset repositioning

Since they don’t necessarily require high-volume spaces, life sciences facilities are well-suited to the adaptation of existing assets. If the stringent vibration and services requirements can be met, there are a myriad of commercial, retail and light industrial spaces which can be converted to suit life sciences functions. This approach drives-down embodied carbon, whilst bringing value to vacant sites, and helping asset owners reduce occupancy voids.

 

Discussing the impact of asset repositioning, Huseyin said: “Recently, we’ve seen a rise in enquiries relating to the retrofit of existing buildings to suit life sciences functionality. With careful analysis of the existing structure and building services arrangements, it’s often possible to deliver the space and amenities required within the specific parameters. For example, at Nottingham’s BioCity development, we repurposed a redundant existing building to create the Laurus, a leading incubator laboratory facility for small to medium sized research and development start-ups. Here, our design enabled the inclusion of flexible spaces suitable for Category 2 laboratories. Using sensitive design interventions, we helped repurpose an existing fixed bench laboratory into a multifunction flexible laboratory space able to expand and contract to meet tenant needs. Our specialists also developed a floor division plan which accommodated a varied layout, with fume cupboard and variable flow air handling facilities able to be tailored to the exact needs of each tenant.”

Once businesses are established in a space, it’s essential that they have room to flex and grow to suit their operational needs. At London’s Project Maple, another existing asset which was repurposed, this flexibility was built into the design from the outset. For this scheme, unhindered adaptability was critical to achieving the required design resilience to support the rapid evolution of the market. To support this, our specialists identified the optimum benching modularity relative to the planning grid and developed considered structural interventions to allow labs to expand and contract to meet the needs of incoming and growing businesses, without hindering the live and operational environment of the asset in which these works would be undertaken.

An eye on the horizon

Considering the future, Huseyin predicts rapid change within the sector: “We are entering a new and exciting era for life sciences, with the rapid evolution of AI-driven drug discovery, diagnostics, and clinical trials boosting efficiency, success rates and product pace to market. In addition, the sector is now looking to expand beyond the traditional Golden Triangle. Developing the infrastructure and connectivity between these areas and the other centres of scientific learning in the midlands, north and south-west will be essential for sustained growth, and will require backing from investors and government-led funding initiatives such as the ‘Innovation Corridor’. These shifts will undoubtedly influence how we design life sciences environments as we strive to integrate these spaces into sustainable, future-ready communities.”

To learn more about how we can support your upcoming life sciences projects, click here to visit our dedicated Life Sciences webpage.